Recognizing the duty of the Federal Government to lead the world in biomedical research.

HRES 601 is a non-binding House resolution recognizing the Federal Government's duty to lead global biomedical research. It expresses Congress's position that NIH funding and scientific independence are critical national assets, emphasizing the need to protect research capacity and double biomedical investment over the next decade. The resolution lists specific goals, including reducing cancer deaths, advancing Alzheimer's research, and improving clinical trial representation, but does not create new laws or allocate funds. It directly addresses the National Institutes of Health (NIH), federal research policy, and the broader biomedical research community. As a symbolic resolution, it has no legal effect but aims to shape future policy discussions.